Abstract
The California Institute for Regenerative Medicine (CIRM) is a state agency charged with accelerating stem cell research through the dispersal of $3 billion in funds for stem cell research. CIRM is partnering with Stem Cells Translational Medicine to launch the Proceedings of the California Stem Cell Agency, a monthly series of commentaries, articles, interviews, webinars, forums, and concise reviews on a wide range of topics in regenerative medicine.